Quick Search:       Advanced Search
Analysis of influencing factors of metastasis and survival difference after endoscopic and surgical treatment in patients with gastric neuroendocrine tumors in stage T1-2
Received:October 16, 2022  Revised:November 15, 2022  Click here to download the full text
Citation of this paper:BAI Bin,LI Heng,WANG Jun,JIANG Wei-ting,ZHU Xu-jun,XU Jian,CAI Hui.Analysis of influencing factors of metastasis and survival difference after endoscopic and surgical treatment in patients with gastric neuroendocrine tumors in stage T1-2[J].Chinese Journal of Clinical Medicine,2023,30(3):432-437
Hits: 848
Download times: 367
Author NameAffiliationE-mail
BAI Bin Department of Gastrointestinal Surgery, Shanghai Baoshan Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai 201900, China  
LI Heng Department of Gastrointestinal Surgery, Shanghai Baoshan Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai 201900, China  
WANG Jun Department of Gastrointestinal Surgery, Shanghai Baoshan Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai 201900, China  
JIANG Wei-ting Department of Gastrointestinal Surgery, Shanghai Baoshan Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai 201900, China  
ZHU Xu-jun Department of Gastrointestinal Surgery, Shanghai Baoshan Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai 201900, China  
XU Jian Department of Gastrointestinal Surgery, Shanghai Baoshan Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai 201900, China  
CAI Hui Department of General Surgery, the First Affiliated Hospital, Naval Medical University, Shanghai 200433, China caihui@smmu.edu.cn 
Abstract:Objective To explore the metastasis rate of gastric neuroendocrine tumors (G-NETs) patients in stage T1-2 and its related risk factors, and to compare the long-term survival results of patients after endoscopic therapy (ET) and surgical treatment. Methods The data in SEER database were analyzed, and 1 258 patients with pathologically diagnosed G-NETs from January 1, 2004 to December 31, 2015 were included. Logistic regression was used to analyze the influencing factors of metastasis of patients with G-NETs. In patients with T1-2N0M0 stage G-NETs, the general clinical characteristics of patients receiving ET or surgery were compared after propensity matching analysis. The difference of 5-year overall survival (OS) and the risk factors affecting OS between the surgery and ET groups were analyzed by Kaplan-Meier survival curve and Cox proportional hazard regression model. Results A total of 851 patients with T1 and T2 G-NETs were followed up for 5 years. Lymph node or distant metastasis occurred in 183 patients (21.5%). The metastasis rates of T1 and T2 G-NETs patients were 14.6% and 33.3%, respectively (P<0.05). Multivariate logistic regression analysis showed that tumor grade G3/4, invasion of lamina propria and tumor diameter >20 mm were closely related to metastasis of T1-2 stage G-NETs. The 5-year survival rate of patients in non-metastasis group (n=668) was 85.1%, and that of patients in metastasis group
(n=183) was 34.7% (P<0.05). Subgroup analysis showed that during the 5-year follow-up, the average survival time of patients with metastasis after surgery and ET treatment was 42.0 months and 31.3 months (χ2=14.510, P<0.05), and the average survival time of patients without metastasis after surgery and ET treatment was 53.2 months and 52.3 months (χ2=0.279, P=0.598). After propensity matching analysis, the 5-year survival rate of patients with T1-2N0M0 G-NETs was similar after ET and surgery (88.8% vs 89.4%, χ2=0.22, P=0.882). Multivariate Cox proportional hazard regression model showed that age, histological grade and depth of invasion were related to OS of patients with T1-2N0M0 G-NETs. Conclusions The tumor grade G3/4, invasion of lamina propria and tumor diameter > 20 mm
might be closely related to the metastasis of G-NET in T1-2 stage, the prognosis of these patients with metastasis is poor. 5-year survival rate in patients with T1~2N0M0 G-NETs are similar after ET and surgery.
keywords:gastric neuroendocrine tumors  endoscopic therapy  surgery  SEER database
HTML  View Full Text  View/Add Comment  Download reader